Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
1.070
-0.010 (-0.93%)
May 13, 2025, 4:00 PM - Market closed
Channel Therapeutics Market Cap
Channel Therapeutics has a market cap or net worth of $6.53 million as of May 14, 2025. Its market cap has decreased by -30.55% in one year.
Market Cap
6.53M
Enterprise Value
8.20M
1-Year Change
-30.55%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since the IPO on February 16, 2024, Channel Therapeutics's market cap has decreased from $33.50M to $6.53M, a decrease of -80.51%. That is a compound annual growth rate of -73.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 6.53M | 69.03% |
| Dec 31, 2024 | 3.86M | -88.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |